With cells showing distinct reactivity to BerEp4, this indicates the presence of carcinoma, and the subsequent diagnostic effort should be directed toward establishing the primary location of the tumor, and when appropriate genetic analyses are relevant to the choice of treatment. This evidence concerns the gene EPCAM and neoplasm.